Impact of comorbidity on chemotherapy use and outcomes in solid tumors: A systematic review

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages 106-117

  Lee, Linda ^a   Cheung, Winson Y ^a   Atkinson, Esther ^a   Krzyzanowska, Monika K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DIABETES MELLITUS; DRUG TOLERABILITY; EMBASE; ENTERITIS; ESOPHAGUS CANCER; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDLINE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SYSTEMATIC REVIEW;

AGED; ANTINEOPLASTIC AGENTS; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79951966462     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.3049     Document Type: Review

References (56)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Yancik R, Havlik RJ, Wesley MN, et al: Cancer and comorbidity in older patients: A descriptive profile. Ann Epidemiol 6:399-412, 1996 (Pubitemid 26372528)
3. Coebergh JW, Janssen-Heijnen ML, Post PN, et al: Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 52:1131-1136, 1999
4. Zeber JE, Copeland LA, Hosek BJ, et al: Cancer rates, medical comorbidities, and treatment modalities in the oldest patients. Crit Rev Oncol Hematol 67:237-242, 2008
5. Gross CP, McAvay GJ, Krumholz HM, et al: The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: Implications for screening. Ann Intern Med 145:646-653, 2006 (Pubitemid 46768839)
6. Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104-110, 1994 (Pubitemid 24027550)
7. Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441-2447, 2004 (Pubitemid 38669187)
8. Geraci JM, Escalante CP, Freeman JL, et al: Comorbid disease and cancer: The need for more relevant conceptual models in health services research. J Clin Oncol 23:7399-7404, 2005 (Pubitemid 46291800)
9. Koroukian SM, Murray P, Madigan E: Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol 24:2304-2310, 2006 (Pubitemid 46630661)
10. Extermann M, Overcash J, Lyman GH, et al: Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16:1582-1587, 1998 (Pubitemid 28175784)
11. Read WL, Tierney RM, Page NC, et al: Differential prognostic impact of comorbidity. J Clin Oncol 22:3099-3103, 2004 (Pubitemid 41103722)
12. von Elm E, Altman DG, Egger M, et al: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med 4:e296, 2007
13. Asmis TR, Ding K, Seymour L, et al: Age and comorbidity as independent prognostic factors in the treatment of non-small-cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 26:54-59, 2008
14. Dy SM, Sharkey P, Herbert R, et al: Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer. Crit Rev Oncol Hematol 59:218-225, 2006 (Pubitemid 44279424)
15. Gonlugur TE, Gonlugur U: Comorbidity as a prognostic factor in small cell lung cancer. Tumori 92:423-428, 2006 (Pubitemid 44861779)
16. Jacot W, Colinet B, Bertrand D, et al: Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 19:1458-1464, 2008
17. Janssen-Heijnen ML, Smulders S, Lemmens VE, et al: Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 59:602-607, 2004 (Pubitemid 38901520)
18. Janssen-Heijnen ML, Lemmens VE, van den Borne BE, et al: Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands. Crit Rev Oncol Hematol 62:172-178, 2007 (Pubitemid 46575272)
19. Juan O, Albert A, Campos JM, et al: Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel. Acta Oncol 46:367-373, 2007 (Pubitemid 46625042)
20. Maestu I, Muñoz J, Gómez-Aldaravi L, et al: Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine. Clin Transl Oncol 9:99-105, 2007
21. Maione P, Perrone F, Gallo C, et al: Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the Multicenter Italian Lung Cancer in the Elderly Study. J Clin Oncol 23:6865-6872, 2005
22. Moscetti L, Nelli F, Padalino D, et al: Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: Impact of comorbidities on safety and efficacy outcome. J Chemother 17:685-692, 2005 (Pubitemid 43097759)
23. Simon GR, Extermann M, Chiappori A, et al: Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older. Cancer 112:2021-2029, 2008 (Pubitemid 351574078)
24. Tammemagi CM, Neslund-Dudas C, Simoff M, et al: In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 57:597-609, 2004
25. Gross CP, McAvay GJ, Guo Z, et al: The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109:2410-2419, 2007 (Pubitemid 46906459)
26. Koroukian SM: Assessment and interpretation of comorbidity burden in older adults with cancer. J Am Geriatr Soc 57:S275-S278, 2009 (suppl 2)
27. Lemmens VE, Janssen-Heijnen ML, Verheij CD, et al: Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 92:615-623, 2005 (Pubitemid 40685658)
28. Luo R, Giordano SH, Freeman JL, et al: Referral to medical oncology: A crucial step in the treatment of older patients with stage III colon cancer. Oncologist 11:1025-1033, 2006 (Pubitemid 44564812)
29. Meyerhardt JA, Catalano PJ, Haller DG, et al: Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21:433-440, 2003 (Pubitemid 46606471)
30. Munro AJ, Bentley AH: Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer. Eur J Cancer Care (Engl) 13:254-262, 2004 (Pubitemid 38834457)
31. Sarfati D, Hill S, Blakely T, et al: The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: A retrospective cohort study. BMC Cancer 9:116, 2009
32. Garg P, Rana F, Gupta R, et al: Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients. Breast J 15:404-408, 2009
33. Hawfield A, Lovato J, Covington D, et al: Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting. Crit Rev Oncol Hematol 59:250-255, 2006 (Pubitemid 44279422)
34. Zauderer M, Patil S, Hurria A: Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Res Treat 117:205-210, 2009
35. Houterman S, Janssen-Heijnen ML, Verheij CD, et al: Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90:2332-2337, 2004 (Pubitemid 38961896)
36. Siegelmann-Danieli N, Khandelwal V, Wood GC, et al: Breast cancer in elderly women: Outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7:59-66, 2006 (Pubitemid 43862836)
37. Maskarinec G, Pagano IS, Yamashiro G, et al: Influences of ethnicity, treatment, and comorbidity on breast cancer survival in Hawaii. J Clin Epidemiol 56:678-685, 2003 (Pubitemid 36960185)
38. Søgaard KK, Cronin-Fenton DP, Pedersen L, et al: Survival in Danish patients with breast cancer and inflammatory bowel disease: A nationwide cohort study. Inflamm Bowel Dis 14:519-525, 2008 (Pubitemid 351571832)
39. Steyerberg EW, Neville B, Weeks JC, et al: Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: A population-based analysis of elderly patients. J Clin Oncol 25:2389-2396, 2007 (Pubitemid 46999209)
40. Maas HA, Kruitwagen RF, Lemmens VE, et al: The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: A population-based study. Gynecol Oncol 97:104-109, 2005 (Pubitemid 40403681)
41. Wright J, Doan T, McBride R, et al: Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. Br J Cancer 98:1197-1203, 2008 (Pubitemid 351481683)
42. Seve P, Sawyer M, Hanson J, et al: The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: A population-based study. Cancer 106:2058-2066, 2006 (Pubitemid 43673223)
43. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al: Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol 55:231-240, 2005 (Pubitemid 41222320)
44. Marinello R, Marenco D, Roglia D, et al: Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients. Arch Gerontol Geriatr 48:222-226, 2009
45. Wedding U, Röhrig B, Klippstein A, et al: Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 133:945-950, 2007 (Pubitemid 47561710)
46. van De Poll-Franse LV, Houterman S, Janssen-Heijnen ML, et al: Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis. Int J Cancer 120:1986-1992, 2007
47. Extermann M: Measuring comorbidity in older cancer patients. Eur J Cancer 36:453-471, 2000
48. Krzyzanowska MK, Regan MM, Powell M, et al: Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg 208:202-209, 2009
49. Hurria A, Wong FL, Pal S, et al: Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: A survey of oncologists. Oncologist 14:883-890, 2009
50. Ozanne EM, Braithwaite D, Sepucha K, et al: Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol 27:214-219, 2009
51. Walter LC, Covinsky KE: Cancer screening in elderly patients: A framework for individualized decision making. JAMA 285:2750-2756, 2001 (Pubitemid 32525372)
52. Etzioni DA, El-Khoueiry AB, Beart RW Jr: Rates and predictors of chemotherapy use for stage III colon cancer: A systematic review. Cancer 113:3279-3289, 2008
53. Yancik R, Ganz PA, Varricchio CG, et al: Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 19:1147-1151, 2001 (Pubitemid 32176292)
54. Hines RB, Chatla C, Bumpers HL, et al: Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 27:4339-4345, 2009
55. Piccirillo JF, Spitznagel EL Jr, Vermani N, et al: Comparison of comorbidity indices for patients with head and neck cancer. Med Care 42:482-486, 2004
56. Townsley CA, Selby R, Siu LL: Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 23:3112-3124, 2005 (Pubitemid 46224135)